Adenosine 5\'-triphosphate (ATP) is most commonly known as the vital carrier of free energy, playing multifaceted roles in energy metabolism, biosynthesis, and intracellular signal transduction. A non-canonical role for ATP in extracellular signal transduction emerged from studies showing that ATP is released from sensory nerves and promotes vasodilatation[@R1]. Subsequently, the concept of ATP-mediated signaling, termed purinergic signaling, was provided by Burnstock as a ubiquitous mechanism for extracellular communication[@R2]. Interest in this field redoubled upon molecular cloning and characterization of two different ATP receptors: ionotropic P2X receptors and G-protein coupled P2Y receptors[@R3]--[@R6]. While the physiological importance of purinergic signaling is now generally accepted[@R7], elucidation of the molecular mechanisms of ATP-binding and the subsequent signal transduction has been hindered due to the absence of high-resolution structures for any ATP receptors.

Ionotropic P2X receptors are widely distributed throughout the human body and participate in diverse physiological processes, from the nervous system to the immune system[@R8]. In the central nervous system, presynaptic neurons expressing P2X receptors enhance the release of neurotransmitters such as glutamate[@R9], [@R10] and γ-aminobutyric acid (GABA)[@R11], [@R12], while expression in postsynaptic neurons is required to evoke ATP-induced postsynaptic current[@R13], [@R14]. In the peripheral nervous system, afferent neurons carrying P2X receptors sense a variety of stimuli such as taste[@R15], pain[@R16], [@R17], and distention of the bladder[@R18]. Furthermore, P2X receptor-deficient mice demonstrate the involvement of these receptors in blood pressure regulation and vascular remodeling, autoregulation of blood flow in retina, and interleukin-1β production from macrophages[@R19]--[@R22]. Because P2X receptors are integral to many signal transduction pathways, it is perhaps not surprising the dysfunction of P2X receptor-mediated signaling is implicated in cancer[@R23], inflammatory[@R24], cardiovascular, and neuronal diseases. P2X receptors are therefore promising targets for new therapeutic agents.

P2X receptors are cation permeable, ATP-gated ion channels derived from seven different subtypes (P2X~1--7~) found in both lower and higher eukaryotes[@R25]. Intact receptors are composed of three subunits assembled as either homomeric or heteromeric complexes contingent upon the specific subunits and the cellular context[@R26]--[@R29]. Gating kinetics and pharmacology vary widely between different homomeric and heteromeric receptor assemblages. Whereas homomeric P2X1 receptors exhibit rapid, nearly complete desensitization and high sensitivity to suramin and PPADS, homomeric P2X4 receptors display slow, incomplete desensitization and insensitivity to common P2X receptor antagonists[@R30]. Secondary structure prediction and hydropathy plots suggest that each subunit has two transmembrane segments arranged such that the intracellular domain is formed by the amino- and the carboxyl-termini. Although the transmembrane (TM) topologies of P2X receptors are similar to acid sensing ion channels (ASICs), epithelial sodium channels (ENaCs), and degenerin channels (DEGs)[@R31], there is little, if any, relationship between their primary amino acid sequences.

Ascertaining the structure of a P2X receptor not only will elaborate upon the architecture of this important class of ligand-gated ion channels and, thus, form the basis for molecular mechanisms of function, but it will also provide new insight into the molecular principles of agonist and antagonist binding, in turn spurring the design of novel therapeutic agents. Here, we show the crystal structure of a zebrafish P2X4 receptor at 3.1 Å resolution, verifying that these receptors are trimers with previously unseen subunit folds and non-canonical ATP binding sites. The closed transmembrane pore, consistent with crystallization of the receptor in the absence of ATP, defines the ion channel gate in a closed, resting state.

Crystallization and structure determination {#S1}
===========================================

P2X receptors tend to aggregate or dissociate in the presence of detergents commonly used for crystallization ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). We therefore employed fluorescence-detection size exclusion chromatography (FSEC) to rapidly and efficiently evaluate the stability and monodispersity of thirty-five P2X orthologs expressed in transiently transfected HEK293 cells[@R32]. The zebrafish P2X4.1 (zfP2X4) receptor emerged as a promising candidate for crystallization trials because it has a sharp and symmetrical elution profile (grey trace, [Fig. 1d](#F1){ref-type="fig"}). The full-length zfP2X4 is activated by ATP with a 50% effective concentration (EC~50~) of \~800 µM ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"})[@R33]. To improve crystallization behavior, however, we analyzed a series of amino and carboxyl termini deletion mutants, settling on a minimal yet functional construct (ΔzfP2X4-A, black trace, [Fig. 1d](#F1){ref-type="fig"}). Further optimization to avoid non-native disulfide bond formation and to reduce heterogeneity resulting from glycosylation yielded a derivative of ΔzfP2X4-A harboring three point mutations (C51F/N78K/N187R; ΔzfP2X4-B; blue trace, [Fig. 1d](#F1){ref-type="fig"}). Electrophysiological experiments revealed that both ΔzfP2X4-A and -B are activated by 1 mM ATP ([Fig. 1b, c](#F1){ref-type="fig"}), although the peak current amplitudes are smaller than those recorded from the full-length receptor ([Fig. 1a](#F1){ref-type="fig"}), an observation consistent with the lower expression levels of the mutants ([Fig. 1d](#F1){ref-type="fig"} and [Supplementary Fig. 2b--d](#SD1){ref-type="supplementary-material"}). The ΔzfP2X4-A structure was solved by single wavelength anomalous diffraction using a gadolinium derivative and the ΔzfP2X4-B structure was solved by molecular replacement.

Architecture {#S2}
============

The homotrimeric zfP2X4 receptor has a chalice-like shape with the large extracellular domain protruding \~70 Å above the membrane plane and the comparatively smaller TM stem extending \~28 Å through the membrane ([Fig. 2a](#F2){ref-type="fig"}). Within the ΔzfP2X4-A receptor complex each of the three subunits adopts a similar conformation, and in the ΔzfP2X4-B structure the subunits are related by the crystallographic three-fold axis of symmetry passing through the receptor center, perpendicular to the putative membrane plane.

The shape of the TM region is reminiscent of an hourglass and is formed by six TM helices, two from each of the three subunits. Within a subunit, the TM helices are oriented approximately antiparallel to one another and are angled nearly 45° from the membrane normal. The inner TM2 helices cross each other about halfway across their membrane-spanning lengths, constricting the TM pore and defining the closed, resting state of the channel. At the cytoplasmic termini of TM1 and TM2 the electron density is weak and we were not able to fit all of the residues to electron density features.

In contrast to the left-handed twist of the TM helices, as seen from the cytoplasmic termini, the extracellular region of each subunit wraps around its neighbor with a right-handed twist, gripping adjacent subunits with extensive contact interfaces ([Fig. 2a](#F2){ref-type="fig"}). The large extracellular domain, when viewed perpendicular to the crystallographic three-fold axis of symmetry, has a corrugated profile, replete with protruding *N*-linked glycosylation moieties. Seen parallel to the three-fold axis, the extracellular domain is shaped like an equilateral triangle ([Fig. 2b](#F2){ref-type="fig"}). Although the TM topology of P2X receptors is similar to that of ASICs and other members of the ENaC/Deg superfamily, the fold of the extracellular domains and the corresponding trimeric quaternary architecture is entirely different from ASICs, tetrameric ionotropic glutamate receptors and pentameric Cys-loop receptors.

Subunit fold and interfaces {#S3}
===========================

The zfP2X4 subunit resembles the shape of a dolphin, with the transmembrane helices and the extracellular region akin to the flukes and the upper body, respectively ([Fig. 3a](#F3){ref-type="fig"}). The central architecture of the extracellular body domain is characterized by a transthyretin-like β-sandwich motif[@R34]. This segment appears structurally rigid and perhaps even resistant to conformational changes because the two β-sheets in the β-sandwich are knit together by extensive contacts. Interestingly, the upper regions of the core β-sheets in the body domain contact neighbouring subunits whereas there are no contacts between adjacent subunits at the base of the extracellular domain, proximal to the TM domain. This conformation may allow the TM helices, which are connected directly to the lower region of the body domain, the latitude to move to an open conformation upon ligand-induced rearrangement of the upper regions. Attached to the body domain are the head domain and three structurally different elements: the dorsal fin, the right flipper, and the left flipper. The head domain adopts a fold similar to an oligo mannose binding protein[@R35] and is defined by three antiparallel β-strands and one α-helix. Electron density is weak between K136 and D141 and we have introduced a corresponding break in the polypeptide chain. We find that all ten conserved cysteine residues in the extracellular region form pairings previously predicted by mutagenesis and electrophysiological studies[@R36], [@R37] ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}).

Subunit-subunit interactions are largely mediated by the extracellular domains and a single subunit buries \~3,750 Å[@R2] of surface area upon trimer formation. The three major subunit-subunit interfaces are: body to body, head to body, and left flipper to dorsal fin ([Fig. 3b](#F3){ref-type="fig"}). On the one hand, the residues forming the core β-sheets in the body domain are highly conserved, suggesting that the body to body interactions represent contacts common to all P2X receptors. On the other hand, the residues in the head, the left flipper, and the dorsal fin are less conserved ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"} and [Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}). We speculate that the head to body and the left flipper to dorsal fin interactions may encode some of the chemical and structural information that guides assembly of homomeric or heteromeric receptors. Subunit-subunit contacts are also likely to play an important role in receptor function and, consistent with this hypothesis, experiments have shown that a single mutation in the left flipper of the P2X3 receptor, D266A (D283 in zfP2X4), considerably slows the rate of receptor desensitization[@R38]. A plausible explanation for the lack of function in homotrimeric P2X6 receptors is that due to \~9 missing residues in the left flipper, subunit-subunit contacts are compromised, decoupling agonist binding from ion channel gating.

Closed, resting state {#S4}
=====================

The ion channel domain consists of three TM2 helices arranged around the crystallographic and molecular three-fold axes of symmetry, positioned to define most of the ion conducting pathway and surrounded by three peripheral TM1 helices ([Fig. 4](#F4){ref-type="fig"}). A solvent accessible surface representation clearly shows that the extracellular vestibule extends only a fraction of the distance across the membrane bilayer, to residues L340 and N341. On the cytoplasmic side of this occlusion, probably 5--10 Å from bulk intracellular solution, there is a solvent-accessible intracellular vestibule. Because the receptor was crystallized in an agonist-free, apo state and because the putative ion permeation pathway is unambiguously occluded, the present structure provides an atomic model for the closed, resting state of P2X receptors.

Ion channel access {#S5}
==================

Inspection of the zfP2X4 structure suggests two pathways by which ions in extracellular solution might access the TM ion channel. The first pathway is through any of three fenestrations located directly above the TM domains, proximal to the extracellular leaflet of the membrane bilayer ([Fig. 4a](#F4){ref-type="fig"}, orange arrow). With openings as large as \~8 Å in diameter, these fenestrations should readily allow Na^+^, K^+^ and Ca^2+^ ions to access the channel. A second possible pathway runs the length of the extracellular domain, along the three-fold axis of symmetry and through two conspicuous vestibules rich in acidic residues ([Fig. 4a, 4b](#F4){ref-type="fig"}). In this apo, closed-state structure the constrictions flanking the top vestibule are too narrow for ions to pass (\~2.3 Å). However, agonist binding may induce conformational changes between subunits, expanding these constrictions and, thus, enabling ions to access the transmembrane ion channel. On the cytoplasmic side of the ion channel, we hypothesize that ions exit or enter the pore via the intracellular vestibule, an inverted cone-like structure that includes the conserved aspartic acid residue, D357, a residue important to receptor assembly[@R39].

Ion channel gate {#S6}
================

What are the solvent accessible boundaries of the ion channel gate and what residues or elements of protein structure define the gate? Viewed from the extracellular surface, residues L340 and N341 define the extracellular boundary of the ion channel gate, with the hydrophobic side chain of L340 occluding the pore ([Fig. 4](#F4){ref-type="fig"}; [Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}). On the opposite side of the membrane, the cytoplasmic gate is defined by A347 and the side chain of L346. The \'center\' of the gate is A344 and it defines the closest association of the TM2 helices. Therefore, the P2X receptor ion channel gate is flanked by primarily hydrophobic residues, includes about two turns of the TM2 α-helix, is composed of a slab of packed protein that is \~8 Å thick, and is consistent with recent cysteine accessibility studies[@R40].

Ion selectivity {#S7}
===============

Based upon the analysis of the current zfP2X4 structure together with the recently solved cASIC1mfc structure[@R41], we speculate upon the molecular basis of cation selectivity in P2X receptors and suggest two distinct yet complementary mechanisms. First, the presence of multiple acidic residues in the central vestibule, immediately above the ion channel, together with D59 and D61 near the extracellular fenestrations, may not only enable the direct binding of cations, but may also create a long range negative electrostatic potential that serves to concentrate cations near the extracellular entrance of the ion channel ([Fig. 5g](#F5){ref-type="fig"}). Second, we suggest that permeant ions interact directly and specifically with the main chain and side chain oxygen atoms within the transmembrane ion channel. Although we have not yet determined the conducting, open channel structure, we speculate that the side chain oxygen atom of N341 may interact directly with permeant ions, perhaps similar to the interactions between D433 and Cs^+^ in the cASICmfc structure[@R41]. As ions progress toward the cytoplasm, main chain carbonyl oxygen atoms from carbonyl groups slightly tipped off of the TM2 helix axis will participate in further protein - ion interactions.

Modulation by Gd^3+^ {#S8}
====================

To solve the structure of the ΔzfP2X4-A construct, we employed a Gd^3+^ derivative and found four highly occupied sites. One site is located in the middle vestibule, on the non-crystallographic axis of three-fold symmetry, and is coordinated by carboxylate groups of E98 residues from each of the three subunits ([Fig. 5a, c, d, g](#F5){ref-type="fig"}). The other three Gd^3+^ sites are located at the periphery of the receptor (one site for each subunit) and are coordinated by the carboxylate group of D184 and the hydroxyl group of an *N*-acetyl-D-glucosamine (NAG) residue attached to N187 ([Fig. 5a, b, d](#F5){ref-type="fig"}). Because P2X receptors are commonly modulated by divalent and trivalent cations and because the Gd^3+^ ions were bound to sites on the zfP2X4 receptor that might play a role in ion channel function, we asked whether Gd^3+^ altered ATP-dependent receptor gating.

Whole cell patch-clamp recordings of tsA201 cells transfected with the ΔzfP2X4-A construct demonstrated that in the presence of 100 µM Gd^3+^ and at a holding potential of −60 mV, coapplication of 30 µM ATP failed to elicit inward current, suggesting that Gd^3+^ is an antagonist ([Fig. 5e, f](#F5){ref-type="fig"}). At positive holding potentials Gd^3+^ continued to antagonize ATP-dependent receptor activation, thus demonstrating that Gd^3+^ was not acting solely as a pore blocker ([Supplementary Fig. 12a](#SD1){ref-type="supplementary-material"}). Although increasing ATP concentrations concomitantly extinguished Gd^3+^ antagonism ([Supplementary Fig. 12c](#SD1){ref-type="supplementary-material"}), raising the possibility that Gd^3+^ might simply sequester ATP, a direct action of Gd^3+^ on the receptor is supported by the fact that preapplication of Gd^3+^ greatly attenuated channel activation as opposed to when ATP was subsequently applied in a Gd^3+^-free solution ([Supplementary Fig. 12a, b](#SD1){ref-type="supplementary-material"}). Furthermore, Gd^+3^ speeds the rate of ion channel deactivation ([Supplementary Fig. 12c](#SD1){ref-type="supplementary-material"}). Finally, the direct action of Gd^3+^ on the receptor is further bolstered by the presence of four highly occupied Gd^3+^ binding sites, one of which is at the \'top\' of the profoundly acidic central vestibule, a cavity that also serve to attract and concentrate cations ([Fig. 5a, g](#F5){ref-type="fig"}).

ATP binding site {#S9}
================

Where is the ATP binding site? We suggest that deep grooves on the outside of the trimer, 45 Å from the ion channel domain and spanning neighbouring subunits, are the binding sites for ATP ([Fig. 6a, b](#F6){ref-type="fig"}). These inter-subunit grooves are populated by eight conserved residues implicated in ATP-dependent P2X receptor gating[@R42]--[@R46] ([Fig. 6c](#F6){ref-type="fig"}) and whose amino acid composition is compatible with an ATP binding motif. This putative ATP site, shaped like an open jaw, is one of three in the receptor, is surrounded by the head domain, the body domain, the right flipper, and the dorsal fin, and includes residues K70, K72, F188, and T189 from one subunit and residues N296, F297, R298, and K316 from the neighbouring subunit. Among those residues, K70, K72, T189, N296, R298, and K316 are oriented toward the groove of the pocket, indicating that they may bind directly to ATP. By contrast, both F188 and F297 are oriented away from the groove, suggesting that they may participate in transducing conformational changes from the binding pocket to the ion channel ([Supplementary Fig. 13](#SD1){ref-type="supplementary-material"}). We speculate that ATP binding induces movement of the head, right flipper and dorsal fin domains, effectively closing these \'jaws\' around the agonist, and thus resulting in conformational changes within and between subunits.

Antagonist binding site {#S10}
=======================

A recent study has shown that the F95L mutation in human P2X7 (I94 in zfP2X4) drastically reduces the sensitivity to allosteric antagonists such as N2-(3,4-difluorophenyl)-N1-(2-methyl-5-(1-piperazinylmethyl)phenyl)glycinamide dihydrochloride (GW791343) and 4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl)1H--imidazole[@R47] (SB203580). Likewise, the R126G mutation (A126 in zfP2X4) reduces the potency of pyridoxalphosphate-6-azophenyl-2\',4\'-disulphonic acid (PPADS). In a different study, North\'s group showed that K138 in human P2X1 (D141 in zfP2X4) is important for the inhibitory effect of suramin[@R48]. Importantly, all residues are located in the vicinity of the predicted ATP binding pocket. Though speculative, we suggest that these antagonists block conformational rearrangements by occupying part or all of the ATP site and precluding closure of the head, right flipper and dorsal fin domain \'jaws\'.

Conclusion {#S11}
==========

We present the first crystal structure of an ATP-gated P2X ion channel in a closed, resting state at 3.1 Å resolution, providing atomic-resolution evidence that these receptors are trimeric in subunit stoichiometry, with each subunit composed of two continuous, transmembrane α-helices, intracellular termini and a large disulfide bond-rich extracellular domain. We propose that ATP binds to a non canonical site \~45 Å from the ion channel domain, in a deep cleft, inducing conformational changes within and between subunits. We speculate that these changes, in turn, are propagated to the ion channel by conserved residues located at the transmembrane domain - extracellular domain interface ([Fig. 6d](#F6){ref-type="fig"}), opening the ion channel pore.

Methods Summary {#S12}
===============

Thirty-five P2X receptor genes fused to EGFP were separately and rapidly screened by transient transfection in human embryonic kidney (HEK-293) cells followed by fluorescence detection size-exclusion chromatography (FSEC). Based on a sharp, symmetric elution profile, the zebrafish P2X4.1 (zfP2X4.1) receptor was identified as a highly promising construct for x-ray crystallographic studies. The shortest well-behaved constructs of zfP2X4.1 (ΔzfP2X4-A or B) were expressed in Sf9 cells using a baculovirus infection system, the membranes were solubilized in *n*-dodecyl-β-D-maltoside (DDM), and the receptor was purified by metal affinity and size-exclusion chromatography. ΔzfP2X4-A crystals were grown in 10--12% PEG 4,000, 100 mM sodium acetate (pH 4.2--4.6), 100 mM ammonium sulfate, and 1 mM GdCl~3~ in D~2~O while ΔzfP2X4-B crystals were obtained with 20% PEG 2000, 100mM Tris (pH 8.4), 300 mM MgNO~3~, and 1 mM GdCl~3~. The ΔzfP2X4-A structure was solved by single-wavelength anomalous diffraction (SAD) using data measured at the gadolinium (Gd) L~III~ edge. SOLVE was employed to determine Gd ion positions and to calculate SAD phases. These initial phases were subsequently improved by density modification using programs in the CCP4 package. Iterative model building and refinement was performed using the crystallography software COOT and PHENIX. The ΔzfP2X4-B structure was determined by molecular replacement. Whole cell patch clamp recordings were performed on tsA201 cells transfected with plasmid DNA encoding zfP2X4.1-EGFP, ΔzfP2X4-A-EGFP or ΔzfP2X4-B-EGFP constructs.

Methods {#S13}
=======

Expression and purification {#S14}
---------------------------

The shortest well-behaved construct of zfP2X4.1 (ΔzfP2X4-A) was determined by examining twelve different combinations of N- and C-termini deletions in Sf9 cells by rapid FSEC analysis. Likewise, the FSEC screening strategy was exploited to identify a well-behaved derivative of ΔzfP2X4-A that carries mutations at two of four glycosylation sites (N78K/N187R) and a point mutation (C51F) in TM1 (ΔzfP2X4-B). The ΔzfP2X4-A protein was expressed as an N-terminal EGFP fusion with an octa-histidine affinity tag (EGFP-His~8~) in baculovirus infected Sf9 cells. Infected Sf9 cells were cultured in serum-free medium (Invitrogen) at 27 ºC for 24 hr post infection after which time the temperature was reduced to 20 ºC. Cells were harvested 72 hr post infection by centrifugation at 6,200 × g and broken by sonication in TBS (50 mM Tris pH 8.0, 150 mM NaCl) supplemented with 1 mM phenylmethanesulphonylfluoride, 5.2 ug/ml aprotinin, 2 ug/ml leupeptin, and 1.4 ug/ml pepstatin A (all from Sigma Aldrige). Cell debris was cleared by a low-speed spin (10,000 × g). Membranes were collected by a high-speed spin at 19,000 × g and solubilized in TBS containing 40 mM DDM (Anatrace). The detergent-soluble fraction was incubated with cobalt-charged metal ion affinity resin (Clontech), and ΔzfP2X4 was eluted with 250 mM imidazole (Fluka) and 1 mM DDM in TBS. After thrombin digestion to remove the EGFP- His~8~ tag, ΔzfP2X4 was isolated by size exclusion chromatography (SEC) in 20 mM HEPES pH 7.0, 80 mM NaCl, 20 mM KCl, and 0.5 mM DDM. Peak fractions were pooled, concentrated to 2 mg/ml, and used for crystallization. All steps following Sf9 cell culture were carried out on ice or at 4 ºC. For the purification of ΔzfP2X4-B, all steps were identical with the exception that 15% glycerol was included in the solubilization, IMAC and SEC elution buffers. For production of selenomethionine (SeMet) labeled receptor, baculovirus infected Sf9 cells were cultured for one day at 27 ºC, harvested by centrifugation at 1,000 × g for 5 min, re-cultured in serum-free medium without methionine for 4 hours at 27 ºC, and then supplemented with 50 mg/L SeMet (Anatrace). After ten hours of incubation at 27 ºC, the temperature was shifted to 20 ºC, and the cells were cultured for another two days before harvesting. SeMet proteins were purified as described above.

Crystallization {#S15}
---------------

For ΔzfP2X4-A, crystals were obtained at 4 ºC in 3--4 weeks by vapor diffusion by mixing 1:1 or 2:1 (v/v) ratios of protein and a reservoir solution containing 10--12 % PEG 4,000, 100 mM sodium acetate (pH 4.2--4.6), 100 mM ammonium sulfate, and 1 mM GdCl~3~ in D~2~O. Crystals were dehydrated and cryo-protected by adding glycerol in 2.5 % steps (final 12.5 %) followed by increasing the PEG 4,000 concentration by 2.5 % steps (final 25 %). For native and SeMet crystals, GdCl~3~ was excluded from the final cryo-protection solution. For ΔzfP2X4-B, crystals were obtained at 4 ºC in nine months by vapor diffusion by mixing 1:1 or 2:1 ratios of protein and a reservoir solution containing 20% PEG 2,000, 300mM Mg(NO~3~)~2~, and 100mM Tris pH 8.4, and 1mM GdCl~3~. Crystals were cryo-protected by adding glycerol in 2.0% steps (final 18%). Crystals were flash frozen in liquid nitrogen and used for X-ray diffraction data collection.

Structure determination {#S16}
-----------------------

X-ray data sets were collected at the Advanced Light Source (beam lines 5.0.2, 8.2.1 and 8.2.2) and at the Advanced Photon Source (beamline 24-ID-E). The diffraction frames were indexed, integrated and scaled using HKL2000. The structure of ΔzfP2X4-A was solved using data from a single-wavelength anomalous diffraction experiment (ALS beamline 5.0.2). The program SOLVE was used to find heavy atom positions and to calculate phases. The phases were improved by density modification that included three-fold non-crystallographic symmetry averaging as carried out by the computer program DM. Initially, several poly-alanine chains were built into the electron density map using COOT. Subsequently, specific protein sequences, together with correct side chain atoms, were fitted to the electron density map based on Met and Cys locations derived from anomalous Fourier difference maps calculated from SeMet data and from native data collected at a low energy (λ=1.6 Å), respectively. Finally, iterative model building using COOT and CCP4 led to a continuous protein model that nevertheless contained a number of Ala residues at positions where the native, longer amino acid side chains were disordered. The resulting structure was manually rebuilt and refined using programs in the CCP4, COOT, and PHENIX packages with the following NCS restraints: B-factor weight=10, coordinate sigma=0.1 for residues 36--64, 119--169, and 326--352, coordinate sigma=0.04 for residues 65--118 and 170--235. The structure of ΔzfP2X4-B was obtained by molecular replacement with the refined model of ΔzfP2X4-A using the program Phaser. The resulting model was manually rebuilt and refined using programs in the CCP4, COOT, and PHENIX packages. The structures were validated by PROCHEK and MOLPROBITY.

Electrophysiology {#S17}
-----------------

Whole-cell patch-clamp experiments were performed on a mammalian cell line (tsA201) transiently expressing EGFP, zfP2X4.1-EGFP, or ΔzfP2X4-A-EGFP, or ΔzfP2X4-B-EGFP constructs using methods previously described. The holding potential was −70 mV unless noted. The pipette solution contained (mM): 115 K-methanesulfonate, 20 NaCl, 1.5 MgCl~2~, 10 HEPES, 10 BAPTA; pH was adjusted to 7.4 with KOH. Standard extracellular solution contained (mM): 140 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, 10 HEPES, 10 MES; pH was adjusted to 7.4 using *N*-methyl-D-glucamine (NMG). ATP test solutions were made from serial dilutions of standard extracellular solution supplemented with 10 mM Na~2~ATP pH 7.4 with NMG. Dilutions were made in standard extracellular solution supplemented with 20 mM NaCl to maintain an equivalent sodium concentration amongst all test solutions. External solutions were exchanged on cells within 20 msec using computer actuated solenoid valves controlling flow through an array of 10 µl pipettes positioned within several hundred micrometers of the cell. All recordings were at room temperature (\~23°C). Data were collected using pClamp (Molecular Devices), analyzed with Clampfit (Molecular Devices) and Origin Lab software, and organized using Excel (Microsoft). To account for run-down of current responses, peak current amplitude for each ATP test was measured and scaled relative to the current evoked by a preceding test of 100µM ATP (a concentration which did not cause run-down). Data were plotted relative to the current evoked by 100 µM ATP and fit to the Hill equation (Origin) to determine the ATP concentration required to evoke a half-maximal current (EC~50~). For presentation, data were normalized to the maximum evoked current (I~max~) of the best fit to the Hill equation.
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![A functional P2X4 receptor for structural studies\
**a, b, c**, Whole cell recordings of ATP-evoked current (1mM, 3sec, grey bars) from the full-length zfP2X4.1-EGFP construct (**a**), the ΔzfP2X4-EGFP-A construct (**b**), and the ΔzfP2X4-EGFP-B construct (**c**). **d**, FSEC profiles for zfP2X4.1-EGFP (grey), ΔzfP2X4-EGFP-A (black), and ΔzfP2X4-EGFP-B (blue) expressed in tsA201 cells. The arrows indicate the estimated elution position of the void volume, the zfP2X4-EGFP receptor (trimer) and free EGFP. **e**, 2Fo-Fc electron density map contoured at 1.2 σ. The blue line represents the Cα trace and the grey bars suggest the boundaries of the outer (out) and inner (in) leaflets of the membrane bilayer. The featured slice depicts TM2 helices but not TM1.](nihms122286f1){#F1}

![The architecture of P2X receptors\
**a**, Stereoview of the homotrimeric ΔzfP2X4 structure viewed parallel to the membrane. Each subunit is depicted in a different colour. *N*-acetylglucosamine (NAG) and glycosylated asparagine residues are shown in stick representation. The grey bars suggest the boundaries of the outer (out) and inner (in) leaflets of the membrane bilayer. **b**, Stereoview of the homotrimeric ΔzfP2X4 structure parallel to the molecular three-fold axis from the extracellular side of the membrane.](nihms122286f2){#F2}

![Subunit fold and intersubunit contacts\
**a**, The ΔzfP2X4 subunit has a dolphin-like shape. Alpha helices (TM1-2 and α2--5), beta strands (β1--14), disulfide bonds (SS1--5), and attached glycans (g2 and 4) are indicated. **b**, Interface of two adjacent subunits. Subunit A and B are shown in a solvent-accessible surface model and a cartoon representation, respectively. The three major subunit-subunit interfaces are emphasized in different panels where the red ellipsoid highlights the interface between the two subunits. Models are coloured according to domains as in panel (**a)**.](nihms122286f3){#F3}

![Closed, resting conformation\
**a**, A sagittal section reveals a closed conformation of the pore and shows that the gate is located about halfway across the membrane bilayer. Three vestibules (upper, central and extracellular vestibules) are located on the molecular 3-fold axis, with the extracellular vestibule connected to the bulk solution through a fenestration (orange arrow). **b**, Pore lining surface calculated by the Hole[@R49] program. Each colour represents a different radius range measured from the receptor centre (red: \<1.15 Å, green: 1.15--2.3 Å, and purple: \>2.3 Å). **c**, Cartoon representations of the transmembrane domain viewed parallel to the membrane plane. P337 and N341 are shown in grey and potential gate residues (L340, G343, A344, and A347) are shown in green. **d**, Transmembrane domain viewed perpendicular to the membrane plane.](nihms122286f4){#F4}

![Gadolinium (Gd^3+^) binding sites\
**a**, Anomalous difference Fourier map contoured at 8.0 σ (purple) and the modeled Gd^3+^ ions (yellow). **b**, A peripheral Gd^3+^ binding site in chain B. Distances between Gd^3+^ and the coordinating carboxyl or hydroxyl groups are shown in angstrom. NAG, *N*-acetylglucosamine **c**, The central Gd^3+^ binding site is coordinated by three E98 residues. **d**, View of the Gd^3+^ binding sites in the homotrimeric ΔzfP2X4 structure parallel to the molecular three-fold axis from the extracellular side of the membrane. **e, f**, Gd^3+^ antagonizes ΔzfP2X4-EGFP whole cell currents measured by patch-clamp electrophysiology. ATP (30µM, 1 sec, black bar) evokes an inward current in tsA201 cells expressing ΔzfP2X4-EGFP (**e**). Pre-application of Gd^3+^ (100µM, 5 sec, grey bar) inhibits the current evoked by ATP (30µM, 1 sec, black bar) (**f**). **g**, Acidic surface on the middle vestibule of ΔzfP2X4. Electrostatic potential surface and cartoon representations of ΔzfP2X4 sliced as in [Figure 4](#F4){ref-type="fig"} **c** show an acidic patch located in the middle of the three subunits. The surface is coloured based on the electrostatic potential contoured from −30 kT (red) to +30 kT (blue). White denotes 0 kT. Surface potential was calculated using APBS tools[@R50] for a ΔzfP2X4 model in which side chain atoms were added to residues without side chain atoms in the crystal structure. The following regions were excluded from the calculation: Y53, N78, and N187.](nihms122286f5){#F5}

![ATP binding site\
**a**, A plausible ATP binding pocket located between two neighbouring subunits is highlighted in the black rectangle on an electrostatic potential surface representation of the trimeric ΔzfP2X4-B receptor. The surface is coloured based on the electrostatic potential contoured from −30 kT (red) to +30 kT (blue). White denotes 0 kT. An ATP molecule, scaled appropriately, is also shown. **b**, A surface representation viewed \~45º from panel (**a**). The head, dorsal fin and left flipper domains forming the \"jaw\" shaped ATP-binding pocket are coloured as in [Fig. 3](#F3){ref-type="fig"}. The putative ATP-binding residues are in blue for subunit A (N296, R298, K316) and in red for subunit B (K70, K72, T189). **c**, Close-up view of the highlighted region in **a** illustrating subunit A (blue) and B (red). Conserved residues implicated in ATP binding[@R42]--[@R45] are labeled, and side chains are in stick representation. Contours from a 2Fo-Fc electron density map drawn around the side chains are in green. The electron density for the side chain of K70 is weak and it has been built as an alanine. **d**, Conserved residues, shown in space filling representation, are located between the ATP binding site and the transmembrane domain - extracellular domain interface. Only residues for a single subunit are shown.](nihms122286f6){#F6}
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